Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 3/2020

01-09-2020 | Review Article

Predatory Publishers/Journals in Medical Sciences: How to Avoid, Stop, and What to Do after Being Scammed by Them?

Author: Yosef Mohammed-Azzam Zakout

Published in: Journal of Gastrointestinal Cancer | Issue 3/2020

Login to get access

Abstract

Purpose

The phenomenon of predatory publishers and journals is one of the recent issues to affect the scientific field. It has negative impacts upon scientific research and harmful consequences, including the spread of pseudo-medical sciences. This article discusses general outlines regarding the concept of predatory journals to clarify this issue for junior researchers and academic workers.

Methods

A brief description of the mechanism of publication within legitimate journals was highlighted. Moreover, the negative impact of this behavior was clarified along with several suggestions that may help authors to avoid predatory journals. Finally, post-predatory publication procedures were discussed, followed by practical steps to eliminate or minimize this phenomenon.

Conclusion

The practice of publishing in the predatory journals needs to be addressed; raising this topic in all academic and research institutions may help minimize the impacts. Moreover, this topic must be part of the curriculum for both undergraduate and graduate courses to draw students’ attention to this issue. Furthermore, actions should be taken against those who deliberately publish their work in such journals.
Literature
1.
go back to reference Kelly J, Sadeghieh T, Adeli K. Peer review in scientific publications: benefits, critiques, & a survival guide. EJIFCC. 2014;25:227–43.PubMedPubMedCentral Kelly J, Sadeghieh T, Adeli K. Peer review in scientific publications: benefits, critiques, & a survival guide. EJIFCC. 2014;25:227–43.PubMedPubMedCentral
2.
go back to reference Sharma H, Verma S. Predatory journals: the rise of worthless biomedical science. J Postgrad Med. 2018;64:226–31.CrossRef Sharma H, Verma S. Predatory journals: the rise of worthless biomedical science. J Postgrad Med. 2018;64:226–31.CrossRef
3.
go back to reference Richtig G, Berger M, Lange-Asschenfeldt B, Aberer W, Richtig E. Problems and challenges of predatory journals. J Eur Acad Dermatol Venereol. 2018;32:1441–9.CrossRef Richtig G, Berger M, Lange-Asschenfeldt B, Aberer W, Richtig E. Problems and challenges of predatory journals. J Eur Acad Dermatol Venereol. 2018;32:1441–9.CrossRef
5.
go back to reference Beall J. Essential information about predatory publishers and journals. Higher Education in Russia and Beyond. 2016;1:7–9. Beall J. Essential information about predatory publishers and journals. Higher Education in Russia and Beyond. 2016;1:7–9.
6.
go back to reference Cobey KD, Lalu MM, Skidmore B, Ahmadzai N, Grudniewicz A, Moher D. What is a predatory journal? A scoping review. 2018;F1000Res, 7:1001. Cobey KD, Lalu MM, Skidmore B, Ahmadzai N, Grudniewicz A, Moher D. What is a predatory journal? A scoping review. 2018;F1000Res, 7:1001.
7.
go back to reference Shen C, Björk BC. ‘Predatory’ open access: a longitudinal study of article volumes and market characteristics. BMC Med. 2015;13:230.CrossRef Shen C, Björk BC. ‘Predatory’ open access: a longitudinal study of article volumes and market characteristics. BMC Med. 2015;13:230.CrossRef
8.
go back to reference Laine C, Winker MA. Identifying predatory or pseudo-journals. Biochem Med (Zagreb). 2017;27:285–91.CrossRef Laine C, Winker MA. Identifying predatory or pseudo-journals. Biochem Med (Zagreb). 2017;27:285–91.CrossRef
9.
go back to reference Cortegiani A, Shafer SL. “Think. Check. Submit.” to avoid predatory publishing. Crit Care. 2018;22:300.CrossRef Cortegiani A, Shafer SL. “Think. Check. Submit.” to avoid predatory publishing. Crit Care. 2018;22:300.CrossRef
10.
go back to reference Memon AR. Predatory journals spamming for publications: what should researchers do? Sci Eng Ethics. 2018;24:1617–39.CrossRef Memon AR. Predatory journals spamming for publications: what should researchers do? Sci Eng Ethics. 2018;24:1617–39.CrossRef
11.
go back to reference Wilkinson TA, Russell CJ, Bennett WE, Cheng ER, Carroll AE. A cross-sectional study of predatory publishing emails received by career development grant awardees. BMJ Open. 2019;9:e027928.CrossRef Wilkinson TA, Russell CJ, Bennett WE, Cheng ER, Carroll AE. A cross-sectional study of predatory publishing emails received by career development grant awardees. BMJ Open. 2019;9:e027928.CrossRef
12.
go back to reference Cobey K. Illegitimate journals scam even senior scientists. Nature. 2017;549:7.CrossRef Cobey K. Illegitimate journals scam even senior scientists. Nature. 2017;549:7.CrossRef
13.
go back to reference Memon AR. Publish or perish: a sign 363 of caution for authors to avoid predatory journals. J Pak Med Assoc. 2017;67:822.PubMed Memon AR. Publish or perish: a sign 363 of caution for authors to avoid predatory journals. J Pak Med Assoc. 2017;67:822.PubMed
14.
go back to reference Kolata G. Many academics are eager to publish in worthless journals. New York Times. 2017:1–4. Kolata G. Many academics are eager to publish in worthless journals. New York Times. 2017:1–4.
15.
go back to reference Memon AR. Revisiting the term predatory open access publishing. J Korean Med Sci. 2019;34:e99.CrossRef Memon AR. Revisiting the term predatory open access publishing. J Korean Med Sci. 2019;34:e99.CrossRef
18.
go back to reference Tennant JP. The state of the art in peer review. FEMS Microbiol Lett. 2018;365:fny204.CrossRef Tennant JP. The state of the art in peer review. FEMS Microbiol Lett. 2018;365:fny204.CrossRef
20.
go back to reference Memon AR. How to respond to and what to do for papers published in predatory journals? Sci Ed. 2018;5:146–9.CrossRef Memon AR. How to respond to and what to do for papers published in predatory journals? Sci Ed. 2018;5:146–9.CrossRef
21.
go back to reference Beall J. Medical publishing triage – chronicling predatory open access publishers. Ann Med Surg (Lond). 2013;2:47–9.CrossRef Beall J. Medical publishing triage – chronicling predatory open access publishers. Ann Med Surg (Lond). 2013;2:47–9.CrossRef
22.
go back to reference Eriksson S, Helgesson G. The false academy: predatory publishing in science and bioethics. Med Health Care Philos. 2017;20:163–70.CrossRef Eriksson S, Helgesson G. The false academy: predatory publishing in science and bioethics. Med Health Care Philos. 2017;20:163–70.CrossRef
23.
go back to reference Khan G, Moher D. Predatory journals: do not enter. UOJM ePub. 2017:1–5. Khan G, Moher D. Predatory journals: do not enter. UOJM ePub. 2017:1–5.
27.
go back to reference Hoffecker L. Cabells scholarly analytics. J Med Libr Assoc. 2018;106:270–2.CrossRef Hoffecker L. Cabells scholarly analytics. J Med Libr Assoc. 2018;106:270–2.CrossRef
28.
go back to reference Teixeira da Silva JA, Tsigaris P. What value do journal whitelists and blacklists have in academia? J Acad Librariansh. 2018;44:781–92.CrossRef Teixeira da Silva JA, Tsigaris P. What value do journal whitelists and blacklists have in academia? J Acad Librariansh. 2018;44:781–92.CrossRef
29.
go back to reference Mercier E, Tardif P, Moore L, Le Sage N, Cameron PA. Invitations received from potential predatory publishers and fraudulent conferences: a 12-month early-career researcher experience. Postgrad Med J. 2018;94:104–8.CrossRef Mercier E, Tardif P, Moore L, Le Sage N, Cameron PA. Invitations received from potential predatory publishers and fraudulent conferences: a 12-month early-career researcher experience. Postgrad Med J. 2018;94:104–8.CrossRef
32.
go back to reference Dobson H. Think. Check. Submit. The campaign helping researchers navigate the scholarly communication landscape. Insights. 2016;29:228–32.CrossRef Dobson H. Think. Check. Submit. The campaign helping researchers navigate the scholarly communication landscape. Insights. 2016;29:228–32.CrossRef
38.
go back to reference Dadkhah M, Darbani SM. What can authors do for the papers they published in predatory journals? Pol Arch Med Wewn. 2016;126:574–5.PubMed Dadkhah M, Darbani SM. What can authors do for the papers they published in predatory journals? Pol Arch Med Wewn. 2016;126:574–5.PubMed
39.
go back to reference Cappell MS. List predatory journal publications separately from genuine scholarly publications as standard for CVs. BMJ. 2015;350:h2470.CrossRef Cappell MS. List predatory journal publications separately from genuine scholarly publications as standard for CVs. BMJ. 2015;350:h2470.CrossRef
40.
go back to reference Moher D, Shamseer L, Cobey KD, Lalu MM, Galipeau J, Avey MT, et al. Stop this waste of people, animals and money. Nature. 2017;549:23–5.CrossRef Moher D, Shamseer L, Cobey KD, Lalu MM, Galipeau J, Avey MT, et al. Stop this waste of people, animals and money. Nature. 2017;549:23–5.CrossRef
41.
go back to reference Teixeira da Silva JA, Tsigaris P. Academics must list all publications on their CV. KOME. 2018;6:94–9.CrossRef Teixeira da Silva JA, Tsigaris P. Academics must list all publications on their CV. KOME. 2018;6:94–9.CrossRef
Metadata
Title
Predatory Publishers/Journals in Medical Sciences: How to Avoid, Stop, and What to Do after Being Scammed by Them?
Author
Yosef Mohammed-Azzam Zakout
Publication date
01-09-2020
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 3/2020
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-020-00418-8

Other articles of this Issue 3/2020

Journal of Gastrointestinal Cancer 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.